This pharmaceutical company, founded in 1991, specializes in developing and distributing prescription medications across key therapy areas like oncology, hematology, ophthalmology, and radiology. They are known for their commitment to providing innovative treatments, particularly for rare diseases (orphan drugs), often partnering with leading companies in the EU and North America for distribution within these regions. They prioritize high-quality products and ethical practices, maintaining GMP certifications and securing product patents. Their dosage forms encompass a range of prescription medications, reflecting their focus on precision medicine and addressing specific patient needs.